Simple Summary Percutaneous interventional radiological techniques offer many
alternatives for treatment of Hepatocellular Carcinoma (HCC) using local anesthesia and …

Local and regional therapies are recommended for patients with hepatocellular carcinoma
(HCC) in very early (Barcelona Clinic Liver Cancer [BCLC] 0), early (BCLC A), and …

Hepatocellular carcinoma (HCC) remains a devastating disease worldwide with a growing
incidence and high mortality rate (1). Very few patients present with early stage disease that …

The treatment of hepatocellular carcinoma (HCC) is rapidly evolving as developments in
loco-regional therapies continue to improve. Image-guided radiofrequency (RF) ablation is …

More than 800,000 people worldwide are diagnosed with HCC (hepatocellular carcinoma)
each year, with approximately 700,000 deaths alone occurring in that same year. Treatment …

Objective: To review the current management, outline recent advances and address
controversies in the management of hepatocellular carcinoma (HCC). Summary of …

Treatment options in locally advanced hepatocellular carcinoma (HCC) have evolved
considerably over the past few years with the recent approval of multiple systemic therapies …

Liver cancer ranks fifth in incidence and fourth in overall cancer-related mortality, with
approximately 854,000 new cases and 810,000 deaths per year worldwide. Hepatocellular …

The major risk factors for hepatocellular carcinoma (HCC) in contemporary clinical practice
are becoming increasingly related to sustained virological response after hepatitis C …

Hepatocellular carcinoma (HCC) is a common cancer with unmet needs and limited effective
therapeutic options. The management strategy for diagnosed HCC is based on Barcelona …